Peter Smith has been named chief scientific officer of H3 Biomedicine. Smith is currently vice president, Drug Discovery Biology, for the Cambridge, MA-based precision medicine oncology company. Before joining H3 Biomedicine in 2011, Smith held various roles in oncology discovery for Millennium Pharmaceuticals/Takeda Oncology. He starts in his new role at H3 Biomedicine on March 1.
Author: Frank Vinluan
Xconomy Editor Frank Vinluan is a business journalist with experience covering technology and life sciences. Based in Raleigh, he was a staff writer at the Triangle Business Journal covering technology, biotechnology and energy before joining MedCityNews.com as North Carolina bureau chief. Prior to moving to North Carolina’s Research Triangle in 2007 he held business reporting positions at The Des Moines Register and The Seattle Times.
View all posts by Frank Vinluan
